DailyIQ
Last updated1 minute ago

GL·Globe Life Inc.

$166.13
+1.01 (+0.61%)
Overnight$166.01-0.12 (-0.07%)
High
$167.30
Open
$166.21
Market Cap
12.74B
52W High
$191.55
Low
$164.40
P. Close
$166.13
P/E
10.51
52W Low
$127.00
Fwd P/E
10.06
DailyIQ Est.
$198.39
Inst. Ownership
44.0%
Short Interest
2.79%
Days to Cover
4.5
Div. Yield
0.76%
Next Ex-Div
~Jan 5
Div. Growth
20+ yrs
Technical Score (1D)
72
BULLISH
News Sentiment
55
BULLISH
GL is running a moderate technical setup on the 1D chart, scoring 72 with a BUY signal and firm momentum. The bullish trend is fully intact and the price structure is constructive - the kind of reading that keeps systematic trend-following strategies engaged. Sentiment at 55 is aligned with the move, providing an additional tailwind that reduces the likelihood of a news-driven reversal interrupting the technical setup. The MACD posture is bearish, which further supports the directional read. Traders in this name are managing positions with stops near $159.37 as the trend-preservation level. A sustained push above $172.65 would signal that the current leg is accelerating rather than just extending, potentially drawing in additional momentum-driven buyers. Trends this clean don't need much active management - the main risk is over-trading around a setup that's already working. Trailing risk toward $159.37 and letting $172.65 act as the next checkpoint, rather than taking profits prematurely on strength, is typically the higher-expectancy approach when moderate trend structure and aligned with sentiment are both confirming the same direction.
LOW TARGET
$166 -0.0%
2 analysts
MEAN TARGET
$193 +16.2%
11 analysts
HIGH TARGET
$225 +35.5%
12 analysts
PRICE RANGE
$166.00 - $225.00
SB / B / H / S / SS
4/14/5/1/1
DAILYIQ EST.
$198.39 (+19.5%)
Sector
Financial Services
Industry
Insurance - Life
Exchange
NYQ
Country
United States
Symbol
GL
Description
Globe Life Inc. is a provider of life and supplemental health insurance solutions, primarily serving the lower-to-middle income demographic within the United States. Its core business operates through three primary segments: Life Insurance, Supplemental Health Insurance, and Investments. Globe Life's portfolio includes a range of products like whole and term life insurance, as well as supplemental health coverage for areas such as accidents, cancer, and critical illnesses. The company distributes its offerings through a multi-channel approach, leveraging direct-to-consumer sales, exclusive agency networks, and independent agents. Originally established in 1900 and formerly known as Torchmark Corporation, Globe Life Inc. is headquartered in McKinney, Texas.
Bought (1Y)
0 shares
$0
Sold (1Y)
243,372 shares
$42.5M
Hensley Robert EdwardEVP & Chief Investment Officer
Option Exercise10,000 shares2026-09-22
Hensley Robert EdwardEVP & Chief Investment Officer
Sell6,656 shares2026-09-22
Hensley Robert EdwardEVP & Chief Investment Officer
Sell3,344 shares2026-09-22
Hensley Robert EdwardEVP & Chief Investment Officer
Option Exercise10,000 shares2026-09-22
MITCHELL ROBERT BRIANEVP, General Counsel and CRO
Option Exercise23,000 shares2026-08-07
71/ 100
Bullish
Overall: Bullish
✓Revenue growing year over year
✓Positive net margin
✓Positive operating cash flow
Gross Margin
21.0%
Net Margin
19.4%
Revenue CAGR
3.1%
Debt / Equity
0.44x
Return on Equity
19.4%
Earnings Summary
Globe Life Inc. is a U.S. life and supplemental health insurance provider that serves lower‑to‑middle income consumers through direct, agency, and independent channels, operating within the broader financial services sector and specifically the life insurance industry. The company’s business model centers on whole and term life policies and supplemental coverage for accidents, cancer, and critical illnesses, with a diversified distribution network that supports steady customer acquisition. Recent quarterly performance shows a mixed trajectory: Q4 2024 EPS of $3.14 beat the $3.12 estimate, while Q1 2025 EPS fell short at $3.07 versus $3.24 expected, yet revenue rose modestly from $1.466B to $1.480B. Q2 2025 EPS of $3.27 surpassed the $3.25 estimate, and revenue edged up to $1.481B, indicating a slight acceleration. Q3 2025 EPS of $4.81 beat the $4.54 estimate, with revenue climbing to $1.513B, marking the strongest quarterly growth in the series. However, Q4 2025 EPS of $3.39 missed the $3.54 estimate, and revenue fell to $1.524B from the $1.578B estimate, suggesting a deceleration. Q1 2026 EPS of $3.43 beat the $3.48 estimate, and revenue rose to $1.561B from the $1.553B estimate, while Q2 2026 EPS of $3.61 missed the $3.79 estimate and revenue slipped to $1.593B from the $1.636B estimate. Historically, Globe Life has delivered year‑over‑year revenue growth in most quarters, with EPS often beating estimates in the first half of the year but missing in the latter half, reflecting a pattern of strong early performance followed by mid‑year volatility. Recent news highlights a dividend increase and share repurchase program announced on Oct 1, underscoring a commitment to shareholder returns, and a Morgan Stanley target cut on Oct 5, which may temper short‑term sentiment but does not alter the company’s fundamental upside.

EPS

EstBeatMiss
$3.00$3.53$4.07$4.60$5.14Q2'25Q3'25Q4'25Q1'26Q2'26Q3'26
QtrEstActual+/−
Q3'26$4.89 - -
Q2'26$3.79$3.61-4.7%
Q1'26$3.48$3.43-1.3%
Q4'25$3.54$3.39-4.2%
Q3'25$4.54$4.81+5.9%
Q2'25$3.25$3.27+0.8%

Revenue

EstBeatMiss
$1.5B$1.5B$1.6B$1.6B$1.7BQ2'25Q3'25Q4'25Q1'26Q2'26Q3'26
QtrEstActual+/−
Q3'26$1.7B - -
Q2'26$1.6B$1.6B-2.7%
Q1'26$1.6B$1.6B+0.5%
Q4'25$1.6B$1.5B-3.4%
Q3'25 - $1.5B -
Q2'25 - $1.5B -

Market Data

GL Stock Snapshot

BULLISH72/100
$166.01−$0.12 (0.1%)
Market cap
12.74B
P/E ratio
10.5
Day range
$164.40 – $167.30
News sentiment
55/100 · Neutral
Analyst target
$192.91 (+16.2%)
Consensus
Buy · 25 analysts
52-week range+30.7% off low · -13.3% from high
$127.00$191.55
Price $166.01 DailyIQ Est. $198.39

GL's technical picture is constructive, with trend and momentum pointing the same direction. Earnings and guidance carry more weight than macro data at this capitalisation.

Behaviour On Record

What GL's own history says about today's numbers

Realized volatility (21d)
12.7% 22nd pct
Below its peak
-11.7%
vs 200-day average
+4.0%
Up days (1y)
53%

Globe Life Inc. is currently running 12.7% annualised volatility over the last 21 sessions. Measured against GL's own 13 years of daily returns rather than a market-wide average, that is the 22nd percentile — unusually subdued by its own history, against a typical reading of 18.3%. The distinction matters because a number that looks calm for one stock is turbulent for another, and the absolute figure on its own tells you neither.

GL is trading -11.7% below its running peak. Across 12 full years on file, its median worst-drawdown-in-a-year was -15.6%, and the deepest was -55.9% in 2024. The current pullback is therefore shallower than what this stock gives back in a typical year, which is context worth having before treating it as a dislocation.

Price sits +4.0% from its 200-day moving average. Against every other day in its history, that gap ranks at the 48th percentile — close to the gap it normally carries. Over the past year GL closed higher on 53% of sessions, and it is currently 1 session into a falling streak.

On October specifically: over 13 years of records, GL finished the month higher 8 of 13 times, with a median return of +1.8% and an average of +1.9%. Its strongest month historically has been November at +4.5% on average, its weakest March at -2.7%. Seasonality is a weak signal on its own — a decade is a small sample and regimes change — but it is a real distribution rather than a rule of thumb.

Overnight risk is measurable too: GL has opened more than 2% away from the prior close in 118 of 3,266 sessions (3.6% of the time), with the largest gaps running +9.3% and -17.4%. For anyone holding through an event, that rate is a better guide to overnight exposure than the intraday range.

Across the last 3 dated reports on file, GL moved an average of 3.4% in the session after earnings, closing higher 2 of those 3 times, with a median move of +1.5% and a largest of -6.9%.

All figures computed from 3,267 daily closes between 2013-10-14 and 2026-10-09, split-adjusted, recomputed daily. Percentiles are against GL's own 13-year history, not a peer group or index.

Sector Rotation

Is money rotating into or out of GL's sector?

Globe Life Inc. sits in the Financials sector, currently ranked 12th of 12 GICS sectors by relative-strength rotation score (improving). Within its narrower Insurance industry group, GL ranks 9th of 15 tracked industries, improving.

Sector rank
#12 of 12
Sector state
Improving
Sector rotation score
27
Industry rank
#9 of 15

Options Market

What is the options market pricing for GL?

CallsPuts

For Globe Life Inc.'s nearest expiry (2026-11-20, 37 days out), open interest is put-heavy, a defensive/bearish tilt (put/call ratio of 4.79).

Put/call ratio (2026-11-20)
4.79
Total open interest
139

Analyst Rating Changes

Are analysts turning bullish or bearish on GL?

Wells Fargo most recently reiterated its rating on Globe Life Inc. to Overweight on Oct 12, 2026 with a price target of $191 (from $190). Over the last 90 days, coverage has run 0 upgrades against 0 downgrades, a net mixed lean.

Latest action
Wells Fargo — Overweight
90-day upgrades
0
90-day downgrades
0
Net rating momentum
0
DateFirmActionRatingPrice target
Oct 12, 2026Wells FargoMaintainedOverweight$190 → $191
Oct 5, 2026Morgan StanleyMaintainedOverweight$208 → $197
Jul 24, 2026Keefe, Bruyette & WoodsMaintainedOutperform$192 → $190
Jul 22, 2026TD CowenMaintainedBuy$215 → $225
Jul 21, 2026JP MorganMaintainedOverweight$181 → $201
Jul 15, 2026Piper SandlerMaintainedOverweight$175 → $200
Jul 13, 2026Evercore ISI GroupMaintainedIn-Line$157 → $176
Jul 13, 2026Keefe, Bruyette & WoodsMaintainedOutperform$180 → $192
Jul 10, 2026JefferiesMaintainedHold$147 → $166
Jul 9, 2026Wells FargoMaintainedOverweight$172 → $193
Jul 6, 2026Morgan StanleyMaintainedOverweight$181 → $208
Jun 23, 2026TD CowenMaintainedBuy$199 → $215

Peers & ETF holders

GL peers & ETF holders

News Sentiment Analysis

Sentiment gathered from recent headlines

55/100
Strong NegativeNeutralStrong Positive
MODERATELY BULLISH

Recent News Coverage

Most recent articles, ranked by recency (click to expand).

10+ articles
What did this article say?
Wells Fargo analyst Wesley Carmichael upgraded Globe Life to an Overweight rating on October 12. The brokerage raised the price target from $190 to $191, signaling confidence in the insurer’s prospects. The move reflects expectations of steady earnings growth and a favorable regulatory environment for life insurance companies.
What did this article say?
Globe Life entered its earnings period with expectations of robust market momentum and improving fundamentals, though analysts noted lingering caution regarding potential headwinds.
What did this article say?
Globe Life Inc. (GL) announced that it will publish its Third Quarter 2026 financial results on October 21, 2026, following the market close. The company will make the earnings press release and related data available on its investor website. A live conference call is scheduled for October 22, 2026, at 11:00 a.m. Eastern, with a replay accessible thereafter. The release outlines GL’s ongoing focus on life and supplemental health insurance for the middle‑income market. No immediate financial guidance or performance commentary was provided in the announcement.
What did this article say?
Morgan Stanley reduced its price target for Globe Life (GL) from $208 to $197, citing a more cautious outlook on the company’s growth prospects. The brokerage maintained an overweight rating, indicating it still views GL as a favorable investment relative to peers. The adjustment reflects a reassessment of GL’s valuation multiples and earnings projections, but does not signal a fundamental change in the company’s business model or risk profile. Analysts noted that the new target still represents a modest upside from current market prices, suggesting confidence in GL’s long‑term trajectory. The downgrade in target may influence short‑term trading but is unlikely to alter the overall positive view of the company’s fundamentals.
What did this article say?
Morgan Stanley analyst Bob Huang reduced Globe Life’s price target from $208 to $197 while keeping an Overweight rating. The downgrade reflects concerns about the company’s earnings outlook and competitive pressures in the life insurance sector. The move signals a modest negative view for the stock, though the rating remains positive relative to the broader market. Investors may interpret the target cut as a warning of potential upside limits for GL.
What did this article say?
Globe Life Inc. continued to strengthen its shareholder return program in October, announcing a modest increase in its quarterly dividend and confirming a new share‑repurchase plan. The company’s earnings growth remained steady, supporting the sustainability of the dividend hike. Management highlighted that the buyback program would be executed at market prices, aiming to improve earnings per share and create additional value for investors. The announcement was well received by analysts, who noted that the company’s return policy aligns with its long‑term capital allocation strategy.
What did this article say?
It cites GL’s modest one‑year beta of 0.3 and notes that the company’s growth has been sluggish compared to peers. The piece highlights concerns about GL’s earnings trajectory and capital intensity, suggesting that the stock may not deliver sufficient upside. The recommendation is to steer clear of GL in favor of higher‑growth alternatives.
What did this article say?
Globe Life Inc. (GL) reported a 12.8% decline from its 52‑week high, falling below its 50‑day moving average since mid‑August. The stock has slipped 5.3% over the past three months, trailing the State Street Financial Select Sector SPDR ETF (XLF) by 2.6%. Year‑to‑date, GL has risen 19.4%, outpacing XLF’s modest gain, while its 52‑week return of 16.8% far exceeds XLF’s 2.6%. The company’s three‑segment structure—Life Insurance, Supplemental Health Insurance, and Investments—remains unchanged, and no new material developments were disclosed.
What did this article say?
Globe Life’s health premiums rose 16% year‑over‑year in the second quarter of 2026, outpacing the 3% growth in life premiums. United American contributed a 29% increase, while Family Heritage added 9% growth. The company also expects roughly $65 million of additional premium from approved Medicare Supplement rate increases. These developments strengthened Globe Life’s 2026 outlook.

Technical Analysis

Real-time indicators across multiple timeframes

72
BULLISH
Momentum rank against about 1,000 stocks and ETFs for this timeframe.
Unlock full technicals
Create a free account to access more indicators and deeper timeframe data.
Institutional & Hedge Fund Ownership
25 tracked managers · $5.60B combined position · 16 adding, 9 trimming, 0 unchanged (latest 13F filings)
ManagerTrendShares Held% of Co.Position ValueFiled
Vanguard Group Inc▲ Buy10,090,88513.15%$1.41B2026-01-29
BlackRock, Inc.▼ Sell5,528,8837.20%$987.90M2026-08-07
Invesco Ltd.▲ Buy4,619,2196.02%$825.36M2026-08-14
Geode Capital Management, LLC▲ Buy2,804,4133.65%$500.42M2026-08-12
Morgan Stanley▲ Buy1,940,5842.53%$346.74M2026-08-13
AQR Capital Management LLC▲ Buy1,515,9871.98%$270.88M2026-08-14
FMR LLC (Fidelity)▲ Buy1,266,8871.65%$226.37M2026-08-13
Norges Bank▼ Sell915,2191.19%$163.53M2026-08-12
Northern Trust Corp▼ Sell768,1221.00%$137.25M2026-08-13
Wellington Management Group LLP▼ Sell761,7980.99%$136.12M2026-08-14
Bank of America Corp▲ Buy680,7590.89%$121.64M2026-08-14
Goldman Sachs Group Inc▼ Sell650,7570.85%$116.28M2026-08-14
Two Sigma Investments, LP▲ Buy308,3230.40%$55.09M2026-08-14
JPMorgan Chase & Co▲ Buy273,4630.36%$49.67M2026-08-12
Gotham Asset Management, LLC▲ Buy253,2720.33%$45.25M2026-08-14
Artisan Partners Limited Partnership▼ Sell190,1080.25%$33.97M2026-08-13
Millennium Management LLC▲ Buy184,7720.24%$33.02M2026-08-14
Adage Capital Partners GP, L.L.C.▲ Buy139,2000.18%$24.87M2026-08-14
Citadel Advisors LLC▼ Sell125,1220.16%$22.36M2026-09-02
Wells Fargo & Company▲ Buy121,2010.16%$21.66M2026-08-14
Neuberger Berman Group LLC▼ Sell99,7840.13%$17.83M2026-08-13
Citigroup Inc▲ Buy85,0460.11%$15.20M2026-08-03
AllianceBernstein L.P.▼ Sell86,5290.11%$12.04M2026-08-14
Bridgewater Associates, LP▲ Buy66,1200.09%$11.81M2026-08-14
Marshall Wace, LLP▲ Buy61,6380.08%$11.01M2026-08-13
Q2 2026 flow:1.89M sh bought ($338.57M)1.11M sh sold ($195.66M)net +786.4K sh (+$142.91M)
Congressional Trading Activity
4 disclosed trades · ~$56.5K est. traded value · 2 buys, 2 sells
MemberChamberStateTypeAmountTradedFiled
Alan ArmstrongSenateOK▲ Buy$1K - $15K2026-03-272026-07-21
Lisa McClainHouseMI09▼ Sell$1K - $15K2025-07-102025-08-13
Lisa McClainHouseMI09▲ Buy$1K - $15K2025-06-172025-08-13
Susan M. CollinsSenateME▼ Sell$15K - $50K2024-08-052024-09-13